These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 16818817

  • 1. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2006 Jul 11; 114(2):135-42. PubMed ID: 16818817
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD, Hlatky MA, Owens DK.
    N Engl J Med; 2005 Oct 06; 353(14):1471-80. PubMed ID: 16207849
    [Abstract] [Full Text] [Related]

  • 3. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G, Freemantle N, Calvert MJ, Bryan S, Daubert JC, Cleland JG.
    Eur Heart J; 2007 Jan 06; 28(1):42-51. PubMed ID: 17110403
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
    Sanders GD, Kong MH, Al-Khatib SM, Peterson ED.
    Am Heart J; 2010 Jul 06; 160(1):122-31. PubMed ID: 20598982
    [Abstract] [Full Text] [Related]

  • 5. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH.
    J Cardiovasc Electrophysiol; 2008 Jul 06; 19(7):720-4. PubMed ID: 18373605
    [Abstract] [Full Text] [Related]

  • 6. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Olshansky B, Wood F, Hellkamp AS, Poole JE, Anderson J, Johnson GW, Boineau R, Domanski MJ, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Am Heart J; 2007 Jun 06; 153(6):1089-94. PubMed ID: 17540216
    [Abstract] [Full Text] [Related]

  • 7. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ, Woo A, Ko DT, Cameron DA, Mihailovic A, Krahn M.
    Am Heart J; 2007 Nov 06; 154(5):899-907. PubMed ID: 17967596
    [Abstract] [Full Text] [Related]

  • 8. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
    Cowie MR, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, de Roy L, Heidbuchel H, Verboven Y, Braunschweig F, Linde C, Boriani G.
    Europace; 2009 Jun 06; 11(6):716-26. PubMed ID: 19359333
    [Abstract] [Full Text] [Related]

  • 9. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS, Hellkamp AS, Halperin JL, Poole J, Anderson J, Johnson G, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    Circulation; 2007 May 22; 115(20):2637-41. PubMed ID: 17485579
    [Abstract] [Full Text] [Related]

  • 10. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ.
    J Am Coll Cardiol; 2006 Jun 06; 47(11):2310-8. PubMed ID: 16750701
    [Abstract] [Full Text] [Related]

  • 11. Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.
    Grimm W, Alter P, Maisch B.
    Herz; 2004 May 06; 29(3):348-52. PubMed ID: 15167963
    [Abstract] [Full Text] [Related]

  • 12. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial.
    Feldman AM, de Lissovoy G, Bristow MR, Saxon LA, De Marco T, Kass DA, Boehmer J, Singh S, Whellan DJ, Carson P, Boscoe A, Baker TM, Gunderman MR.
    J Am Coll Cardiol; 2005 Dec 20; 46(12):2311-21. PubMed ID: 16360064
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS, Stein K, Chow T, Fendrick M, Bigger JT, Vijan S.
    J Am Coll Cardiol; 2006 Jul 04; 48(1):112-21. PubMed ID: 16814657
    [Abstract] [Full Text] [Related]

  • 14. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.
    N Engl J Med; 2005 Jan 20; 352(3):225-37. PubMed ID: 15659722
    [Abstract] [Full Text] [Related]

  • 15. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W, Piotrowicz K, McNitt S, Moss AJ, MADIT II Investigators.
    Am J Cardiol; 2005 Jun 15; 95(12):1487-91. PubMed ID: 15950580
    [Abstract] [Full Text] [Related]

  • 16. The cost effectiveness and cost utility of valsartan in chronic heart failure therapy in Italy: a probabilistic markov model.
    Pradelli L, Iannazzo S, Zaniolo O.
    Am J Cardiovasc Drugs; 2009 Jun 15; 9(6):383-92. PubMed ID: 19929036
    [Abstract] [Full Text] [Related]

  • 17. Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
    Olshansky B, Poole JE, Johnson G, Anderson J, Hellkamp AS, Packer D, Mark DB, Lee KL, Bardy GH, SCD-HeFT Investigators.
    J Am Coll Cardiol; 2008 Apr 01; 51(13):1277-82. PubMed ID: 18371559
    [Abstract] [Full Text] [Related]

  • 18. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.
    Europace; 2004 Jul 01; 6(4):257-66. PubMed ID: 15172648
    [Abstract] [Full Text] [Related]

  • 19. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2005 Jul 01; 5(14):1-74. PubMed ID: 23074465
    [Abstract] [Full Text] [Related]

  • 20. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.
    Eur Heart J; 2007 Jul 01; 28(14):1746-9. PubMed ID: 17283003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.